在"一个健康"的背景下,替代抗生素的可持续畜牧生产:应对共同的敌人
Eveline M Ibeagha-Awemu1, Faith A Omonijo1, Laurie C Piché2
1Sherbrooke Research and Development Centre, Agriculture and Agri-Food Canada, Sherbrooke, QC, Canada.
Frontiers in veterinary science
|August 29, 2025
概括
抗微生物生长促进剂 (AGPs) 改善了牲畜的生产,但导致了抗微生物耐药性 (AMR). 有效的AGP替代品很少,因此需要研究用于AMR缓解和可持续动物养殖的联合策略.
科学领域:
- 动物科学
- 动物医学
- 公共卫生
背景情况:
- 抗菌生长促进剂 (AGP) 在牲畜中广泛用于增长和预防疾病,为全球食品动物产业做出了重大贡献.
- 尽管有好处,但AGP的使用导致了广泛的抗菌药物耐药性 (AMR),在"单一健康"框架下对人类,动物和环境健康构成重大威胁.
- 全球禁止农产品迫切需要确定和开发有效的替代品来维持牲畜的生产力和健康.
研究的目的:
- 审查在禁用前和禁用后使用抗菌生长促进剂 (AGP) 的当前趋势.
- 评估报告的AGP替代品的疗效,作用方式和经济影响.
- 确定挑战,研究缺口和未来发展有效的AGP替代品和促进无AGP动物养殖的战略.
主要方法:
- 关于使用AGP,AMR和替代策略的综合文献综述.
- 分析各种AGP替代品的好处和机制的研究结果.
- 审查经济影响和阻碍有效替代品发展的因素.
主要成果:
- 在食品动物中使用的抗菌剂中,AGP的使用率高达70%,导致AMR的严重问题.
- 目前的AGP替代品显示效果不一致,没有任何一种替代品完全复制了抗菌功能.
- 替代方案的经济影响各不相同,多种因素阻碍了寻找广泛有效的解决方案.
结论:
- 寻找有效的AGP替代品需要加强研究,专注于组合方法而不是单一产品.
- 了解替代品的经济和机械方面对于在无 AGP 系统中成功实施至关重要.
- 未来的战略必须解决研究缺口,以确保可持续的畜牧业生产,同时打击抗菌素耐药性.
相关概念视频
Biological Methods for Microbial Control
199
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
199
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Antibiotic Selection
55.2K
Overview
55.2K
Development of Antibiotic Resistance
197
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Infection
8.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.7K


